December 20, 2023
Shionogi said on December 19 that its group company Ping An-Shionogi (Hong Kong) struck a sub-license agreement with Singapore-based Juniper Therapeutics for its COVID-19 treatment Xocova (ensitrelvir) in the city state. As per the deal, Ping An-Shionogi will grant Juniper...read more